Načítá se...
Caplacizumab for Acute Thrombotic Thrombocytopenic Purpura
Acute thrombotic thrombocytopenic purpura (aTTP) is a rare microangiopathic hemolytic anemia. Standard of care currently includes plasma exchange and immunosuppressive agents, including glucocorticoids, vincristine, and rituximab. Even with these therapies, relapse occurs in 36% of patients, and mor...
Uloženo v:
| Vydáno v: | J Adv Pract Oncol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Harborside Press LLC
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8017799/ https://ncbi.nlm.nih.gov/pubmed/34109052 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jadpro.2021.12.2.8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|